Medicare IVIG Demonstration Extension Act of 2017
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 10, 2017)
Medicare IVIG Demonstration Extension Act of 2017
This bill amends the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 to extend the Medicare Intravenous Immune Globulin (IVIG) demonstration project through 2020, subject to the availability of funds. (This demonstration project provides for bundled Medicare payments with respect to certain items and services that are necessary to administer IVIG in the home.) A Medicare beneficiary who is enrolled in the project on September 30, 2017, shall be automatically reenrolled, subject to an existing cap on project participants.
What just happenedJul 20, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJul 10, 2017
- Jul 20, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 14, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 10, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jul 10, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jul 10, 2017IntroReferralIntro-H
Introduced in House
- Jul 10, 2017IntroReferral1000
Introduced in House